To evaluate the efficacy of a novel sodium-glucose cotransporter-2 (SGLT2) inhibitor in preventing cardiovascular mortality, a multicenter, double-blind trial enrolls patients with chronic heart failure. Participants are randomly assigned to receive either the SGLT2 inhibitor or a placebo. After a median follow-up of three years, the data are analyzed. Among the patients in the intervention group, experienced a cardiovascular mortality event. In the control group, which also consisted of patients, experienced a cardiovascular mortality event. Based on these findings, what is the number needed to treat to prevent one cardiovascular mortality event over the study period?
Answer: 25 patients
Answer
25 patients
The Number Needed to Treat (NNT) represents the number of patients who must receive a particular intervention in order to prevent one additional adverse outcome. It is calculated as (Absolute Risk Reduction). In this study, the control event rate (CER) is , and the experimental event rate (EER) is . The ARR is . The inverse of () yields an NNT of . Therefore, patients need to be treated with the SGLT2 inhibitor to prevent one cardiovascular mortality event.
Step-by-Step Solution
Key Concept
Number Needed to Treat (NNT) is calculated as the inverse of the Absolute Risk Reduction (ARR).